Disaccharide Pyrimidine Nucleosides and Their Derivatives: A Novel Group of Cell-Penetrating Inhibitors of Poly(ADP-Ribose) Polymerase 1

Nearly 30 synthetic nucleosides were tested with human recombinant poly(ADP-ribose) polymerase 1 as potential inhibitors of this enzyme. The most active compounds were some disaccharide analogues of thymidine: 3′-O-β-D-ribofuranosyl-5-iodo-dUrd (2d; IC50 = 45 μM), 3′-O-β-D-ribofuranosyl-2′-deoxythymidine (2e; IC50 = 38 μM), and 3′-O-β-D-ribofuranosyl-2′-deoxythymidine oxidized (4; IC50 = 25 μM). These compounds also reduced H2O2-induced synthesis of poly(ADP-ribose) in cultured human ovarian carcinoma (SKOV-3) cells in a dose-dependent manner. Furthermore, compounds 2d or 2e until a concentration of 1 mM did not affect growth of SKOV-3 cells, whereas dialdehyde compound 4, as well as thymidine, exhibited a significant cytotoxicity.

[1]  E. De Clercq.  Highlights in antiviral drug research: antivirals at the horizon. , 2013, Medicinal research reviews.

[2]  William Lewis,et al.  The role of transporters in the toxicity of nucleoside and nucleotide analogs , 2012, Expert opinion on drug metabolism & toxicology.

[3]  W. Kraus,et al.  On PAR with PARP: cellular stress signaling through poly(ADP-ribose) and PARP-1. , 2012, Genes & development.

[4]  Alexey A. Zeifman,et al.  Hit clustering can improve virtual fragment screening: CDK2 and PARP1 case studies , 2012, Journal of Molecular Modeling.

[5]  D. Filippov,et al.  Ribosylation of adenosine: an orthogonally protected building block for the synthesis of ADP-ribosyl oligomers. , 2011, Organic letters.

[6]  D. Ferraris,et al.  Evolution of poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors. From concept to clinic. , 2010, Journal of medicinal chemistry.

[7]  T. Yap,et al.  Poly(ADP-ribose) polymerase inhibitors in cancer treatment: a clinical perspective. , 2010, European journal of cancer.

[8]  M. Pastor-Anglada,et al.  Nucleoside transporter proteins. , 2009, Current vascular pharmacology.

[9]  W. Parker.  Enzymology of purine and pyrimidine antimetabolites used in the treatment of cancer. , 2009, Chemical reviews.

[10]  J. Rzeszowska-Wolny,et al.  Inhibition of poly(ADP-ribose) polymerase activity affects its subcellular localization and DNA strand break rejoining. , 2009, Acta biochimica Polonica.

[11]  S. Mikhailov,et al.  Disaccharide nucleosides as an important group of natural compounds , 2009, Molecular Biology.

[12]  P. Herdewijn,et al.  Synthesis of 2'-O-α-D-ribofuranosyladenosine, monomeric unit of poly(ADP-ribose) , 2008 .

[13]  S. Mikhailov,et al.  Disaccharide Nucleosides and Their Incorporation into Oligonucleotides , 2007 .

[14]  S. Mikhailov,et al.  Periodate oxidation in chemistry of nucleic acids: Dialdehyde derivatives of nucleosides, nucleotides, and oligonucleotides (Review) , 2000, Russian Journal of Bioorganic Chemistry.

[15]  M. Hottiger,et al.  Nuclear ADP-Ribosylation Reactions in Mammalian Cells: Where Are We Today and Where Are We Going? , 2006, Microbiology and Molecular Biology Reviews.

[16]  Stephen A Baldwin,et al.  Nucleoside transporters: from scavengers to novel therapeutic targets. , 2006, Trends in pharmacological sciences.

[17]  S. Khodyreva,et al.  [Poly(ADP-ribose) polymerase-1 as a regulator of protein-nucleic acid interactions in the processes responding to genotoxic action]. , 2004, Molekuliarnaia biologiia.

[18]  S. Khodyreva,et al.  Poly(ADP-ribose) polymerase-1: A Regulator of Protein–Nucleic Acid Interactions in Processes Responding to Genotoxic Impact , 2004, Molecular Biology.

[19]  S. Khodyreva,et al.  Poly(ADP-ribose) Polymerase-1 Inhibits Strand-Displacement Synthesis of DNA Catalyzed by DNA Polymerase β , 2004, Biochemistry (Moscow).

[20]  S. Mikhailov,et al.  Effective Anomerisation of 2′‐Deoxyadenosine Derivatives During Disaccharide Nucleoside Synthesis , 2004, Nucleosides, nucleotides & nucleic acids.

[21]  K. Ueda,et al.  Inhibitors and activators of ADP-ribosylation reactions , 1994, Molecular and Cellular Biochemistry.

[22]  Ekaterina V Efimtseva,et al.  Disaccharide nucleosides , 2004 .

[23]  S. Khodyreva,et al.  Poly(ADP-ribose) polymerase-1 inhibits strand-displacement synthesis of DNA catalyzed by DNA polymerase beta. , 2004, Biochemistry. Biokhimiia.

[24]  P. Herdewijn,et al.  Synthesis and Properties of Phosphorylated 3′-O-β-D-Ribofuranosyl-2′-deoxythymidine , 2003, Nucleosides, nucleotides & nucleic acids.

[25]  N. Myasoedov,et al.  Chemical and enzymatic synthesis of tritium labelled coenzymes , 2003 .

[26]  K. Schlemmer,et al.  Substituted uracil derivatives as potent inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1). , 2002, Bioorganic & medicinal chemistry letters.

[27]  S. Mikhailov,et al.  [Periodate oxidation in chemistry of nucleic acid. Dialdehyde derivatives of nucleosides, nucleotides, and oligonucleotides]. , 2001, Bioorganicheskaia khimiia.

[28]  A. Khokhlov,et al.  [Enzymatic synthesis of beta-NAD+ selectively marked with tritium at adenine and its use for determining the activity of poly(ADP-ribose) polymerase]. , 1999, Prikladnaia biokhimiia i mikrobiologiia.

[29]  G. Poirier,et al.  Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions. , 1999, The Biochemical journal.

[30]  P. Herdewijn,et al.  An Efficient Synthesis and Physico‐Chemical Properties of 2′‐O‐D‐ Ribofuranosylnucleosides, Minor tRNA Components. , 1997 .

[31]  P. Herdewijn,et al.  AN EFFICIENT SYNTHESIS AND PHYSICO-CHEMICAL PROPERTIES OF 2'-O-D-RIBOFURANOSYLNUCLEOSIDES, MINOR TRNA COMPONENTS , 1997 .

[32]  P. Herdewijn,et al.  Ribosylation of pyrimidine 2'-deoxynucleosides , 1996 .

[33]  P. Herdewijn,et al.  Synthesis and Properties of Some 2′-O-d-Ribofuranosyl-nucleosides , 1995 .

[34]  W. Prusoff,et al.  Inhibition of poly(ADP-ribose)polymerase activity by nucleoside analogs of thymidine. , 1992, Biochemical pharmacology.

[35]  K. Ueda,et al.  Specific inhibitors of poly(ADP-ribose) synthetase and mono(ADP-ribosyl)transferase. , 1992, The Journal of biological chemistry.

[36]  J. Moss,et al.  Quantitative studies of inhibitors of ADP-ribosylation in vitro and in vivo. , 1989, The Journal of biological chemistry.

[37]  V. L. Florent’ev,et al.  Acyclic analogs of nucleosides. Synthesis of 1,5-dihydroxy-3-oxa-2-pentyl derivatives of nucleic bases , 1988 .

[38]  B. Mirkin,et al.  Cytotoxic action of adenosine nucleoside and dialdehyde analogues on murine neuroblastoma in tissue culture: structure-activity relationships. , 1987, Cancer research.

[39]  V. Florentiev,et al.  Convenient Synthesis of Partially Blocked Oxidized-Reduced Nucleosides , 1985 .

[40]  R. T. Walker,et al.  Solution structures of some ‘uridine dialdehyde’ derivatives , 1984 .

[41]  J. G. Cory,et al.  Dialdehyde derivative of 5'-deoxyinosine as a more potent analog of the dialdehyde derivative of inosine (NSC 118994). , 1979, Biochemical pharmacology.

[42]  Shaughnessy Sl,et al.  A 'clinical perspective'. , 1977, Group practice.

[43]  P. Plagemann,et al.  Mechanism of action of inosine dialdehyde (NSC 118994) in the inhibition of proliferation of tumor cells in culture. , 1977, Cancer research.

[44]  A. Mittelman,et al.  Clinical phase I trial of inosine dialdehyde (NSC-118994). , 1975, Cancer chemotherapy reports.

[45]  J. Preiss,et al.  Specific inhibition of poly adpribose polymerase by thymidine and nicotinamide in HeLa cells , 1971, FEBS letters.

[46]  J. Bell,et al.  Immunosuppressive and antitumor activity of periodate oxidation product of beta-D-ribosyl-6-methylthiopurine. , 1968, Cancer research.